The Cures Act provisions. Read the 2018 Report to Congress Annual Update on the Adoption of a Nationwide System for the Electronic Use and Exchange of Health Information.
1. What are the three provisions outlined in The Cures Act? Explain each provision.
2. Who are the three groups of stakeholders that will benefit from interoperability. Discuss (not list) the benefits outlined in the 2018 report of interoperability for each of the three groups individually (70 words minimum)
3. Discuss (not list) the limitations related to information access the three groups of stakeholders face? (70 words minimum)
4. Which provider group has the most capabilities to electronically send or receive (exchange) patient health information with any health care providers outside their organization? What percentage of this provider group has this capability?
5. Which capability is the lacking the most (lowest percentage) in each of the two provider groups outlined? They aren’t necessarily lacking in the same areas. Discuss, do not simply state, each area for each provider group.
6. Explain the basics of APIs in 100-200 words as it relates to health informatics.
The Cures Act measures specific to interoperability and information blocking or denying or limiting access to patient health information, providing unprecedented access, exchange, and usage of electronic health information (EHI) to patients and healthcare providers.
With 95 percent of hospitals and over 85 percent of office practices using EHRs, reports Fager, Amsler Keller & Schoppmann, LLP (FAKS), the law’s complex regulatory requirements impact nearly all healthcare providers. Of particular note, the Act limits information blocking and requires a multifaceted review of existing procedures.
To comply, FAKS recommends medical, legal and information technology staff and/or consultants do the following:
MLMIC cautions that failure to adhere to the Cures Act can result in significant fines. Additionally, we encourage policyholders to review FAKS detailed summary of 21st Century Cures Act and to contact the firm with any questions regarding the Act or its applications.